![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
Consider the four “P’s” of generic drugs that support the case for wider adoption of generics in the health system and beyond.
Instant Assessment: How Mature is Your Health System’s Unsaleable Returns Program?
Learn how McKesson’s Rapid Returns Solution can help improve your unsaleable returns program.
By
Date
March 14, 2024
Read time: 2 minutes
By: McKesson Health Systems Editorial Team
The McKesson Rapid Returns Solution (MRRS), which is also available to health system customers as an on-site model, helps you maximize credit for returned pharmaceuticals and OTC products, credits you faster, and simplifies the returns process so you gain more time for your patients. With MRRS, intended for McKesson-purchased items only, you send one no-cost shipment to one processor. McKesson pays for shipping, processing, and destruction, safeguarding for safe, responsible handling and disposal of un-used drugs. The solution makes it simple to return items, such as:
- Unsaleable controlled substances (II-V)
- Unsaleable pharmaceuticals with six months or less remaining shelf life
- Unsaleable over-the-counter products with three months or less remaining shelf life
- Unsaleable recalled products
The credit you earn is applied to your McKesson account 30 days after your return is processed, reducing your overall costs and improving your bottom line.
To learn more about how McKesson’s Rapid Returns Solution may help improve your current unsaleable returns program, take this instant assessment now.
Additional information is available in the MRRS brochure, available here for instant download (PDF, 168 KB).
Related Stories
Download this checklist for an at-a-glance view of important considerations when modernizing your health system’s infusion service line.
The most downloaded content by health system pharmacy leaders in August 2025.
With available labor resources dwindling and a shrinking pipeline, health systems must find creative solutions for better using the personnel and partnerships they have.
At this year's event, our experts heard from health systems who may be underutilizing available tools and resources in 340B program management.
Click through this interactive experience for a closer look at what you can expect at this year’s HealthTrust University Conference.
Our experts continue shaping industry conversations through regular conference and event engagements, like the HealthTrust University 340B Summit.
The most downloaded content by health system pharmacy leaders in July 2025.
A recent podcast includes first-hand insights on opportunities for collaboration in strengthening the supply chain to achieve more.
McKesson’s Head of Cell, Gene, and Advanced Therapies discusses opportunities and challenges with CGT in the health system.